Creative Enzymes Introduces S-Adenosyl-L-Homocysteine Hydrolase, Recombinant

Posted on 30 August, 2024 by Iva Colter

Creative Enzymes, a global leader in enzyme production, is thrilled to announce the latest addition to their hydrolase product line, the Recombinant S-Adenosyl-L-Homocysteine Hydrolase (SAHH). This announcement underscores its unwavering commitment to enzyme innovation and proven track to offering scientifically advanced products.

SAHH, a crucial enzyme involved in the biological methylation process, is gaining recognition in the scientific community. This enzyme plays a fundamental role in various biological processes including gene expression, protein function, and metabolic activity. Thus, having a quality and reliable source of SAHH is vital for research institutions and industries to advance their understanding and application of this pivotal enzyme.

The new recombinantly produced SAHH offered by Creative Enzymes stands apart given its high purity and stability. Recombinant indicates that this enzyme is produced using advanced biotechnological methods, specifically genetic engineering. This method ensures fidelity and reproducibility of the enzyme, which are essential for consistent research results and large-scale applications. The stability of the enzyme likewise allows for prolonged storage and usage making it cost-effective for researchers and industry players.

“Recombinantly produced enzymes have gained an upswing in preference amongst researchers in recent times due to their superior features, and our new introduction of Recombinant S-Adenosyl-L-Homocysteine Hydrolase echoes this direction,” remarked the senior scientist at Creative Enzymes. “Our goal at Creative Enzymes has always been to provide premium enzymatic products and services that contribute to the advancement of life sciences and associated industries. The launch of this product is a clear example of our continued commitment to this mission.”

SAHH finds application in a plethora of research fields, such as molecular biology, gene expression studies, and drug metabolism research. Its role in the regulation of cellular methylation states makes it an attractive target for pharmaceutical interventions. Inhibition of this enzyme can produce therapeutic effects in disease states like cancer, rheumatoid arthritis, and cardiovascular disease.

Creative Enzymes is known in the enzyme industry for providing a comprehensive range of enzymes, especially for its hydrolases category. The company has over the years developed an extensive portfolio of hydrolases that caters to various scientific research and industrial production needs. The introduction of Recombinant SAHH further strengths its hydrolases offerings and positions Creative Enzymes as a comprehensive provider of innovative enzyme products.

Creative Enzymes will continue its noble pursuit of exploring the enigmatic world of enzymes, contributing to meaningful scientific discoveries and advancements that will bring about positive impacts on human health and our economy.

About Creative Enzymes

Creative Enzymes stands as a leading provider of enzyme-related services and solutions. Committed to innovation and excellence, the organization supports research in enzymology and biotechnology by offering a range of specialized services, including enzyme screening, assay development, and more.

Contact

Address: Shirley, NY 11967, USA

Email: contact@creative-enzymes.com